logo
European Undervalued Small Caps With Insider Buying For June 2025

European Undervalued Small Caps With Insider Buying For June 2025

Yahoo16-06-2025
As European markets grapple with renewed uncertainty due to U.S. trade policy and escalating geopolitical tensions in the Middle East, small-cap stocks have experienced notable volatility, as reflected by a 1.57% decline in the STOXX Europe 600 Index. In this environment, identifying companies with strong fundamentals and potential for growth can be particularly appealing to investors looking for opportunities amid broader market fluctuations.
Name
PE
PS
Discount to Fair Value
Value Rating
Morgan Advanced Materials
11.8x
0.5x
34.62%
★★★★★☆
Europris
19.2x
1.0x
35.38%
★★★★☆☆
Tristel
29.3x
4.1x
8.87%
★★★★☆☆
AKVA group
18.4x
0.8x
48.25%
★★★★☆☆
Close Brothers Group
NA
0.6x
39.71%
★★★★☆☆
Italmobiliare
11.5x
1.5x
-209.43%
★★★☆☆☆
Fuller Smith & Turner
12.0x
0.9x
-55.12%
★★★☆☆☆
SmartCraft
43.6x
7.8x
30.41%
★★★☆☆☆
H+H International
32.2x
0.7x
46.62%
★★★☆☆☆
Seeing Machines
NA
2.2x
48.38%
★★★☆☆☆
Click here to see the full list of 78 stocks from our Undervalued European Small Caps With Insider Buying screener.
Here we highlight a subset of our preferred stocks from the screener.
Simply Wall St Value Rating: ★★★★★★
Overview: MJ Gleeson is a UK-based company primarily engaged in urban regeneration and residential property development, with operations in land promotion through Gleeson Land and home building via Gleeson Homes, and it has a market cap of approximately £0.36 billion.
Operations: The company generates revenue primarily from Gleeson Homes, contributing £343.33 million, while Gleeson Land adds £8.40 million. Over recent periods, the gross profit margin has decreased to 22.32%, indicating a decline in profitability relative to earlier figures such as 34.26%. Operating expenses have consistently impacted net income margins, with the latest figure at 4.70%.
PE: 13.7x
MJ Gleeson, a player in the European market, is drawing attention due to its potential for growth and insider confidence. Between January and May 2025, insiders purchased shares, signaling trust in the company's trajectory. Despite relying solely on external borrowing for funding—considered higher risk—the company forecasts earnings growth of 17.93% annually. This positions it as an intriguing option among smaller stocks with room for expansion in the housing sector.
Click here to discover the nuances of MJ Gleeson with our detailed analytical valuation report.
Review our historical performance report to gain insights into MJ Gleeson's's past performance.
Simply Wall St Value Rating: ★★★☆☆☆
Overview: WH Smith operates as a retail company with a focus on travel and high street locations, boasting a market capitalization of approximately £1.95 billion.
Operations: The company's revenue is primarily derived from its Travel segment, which significantly outpaces the High Street segment. Over time, the gross profit margin has shown an upward trend, reaching 63.82% in February 2025. Operating expenses are a major component of costs, with sales and marketing consistently being the largest expense category. Despite fluctuations in net income margin due to varying non-operating expenses and other factors, recent periods indicate some recovery in profitability metrics.
PE: 193.1x
WH Smith, a notable player in travel retail, is capturing attention with its strategic moves and financial maneuvers. Recently, Palliser Capital acquired nearly 5% of the company to scrutinize leverage and capital allocation for better shareholder returns. The firm repurchased 2.2 million shares for £27 million by April 2025, showcasing confidence in its prospects despite reporting a net loss of £43 million for the half-year ending February 2025. Leadership changes in India signal an ambitious revenue tripling goal over four years under Shantanu Chakravartty's guidance. With travel revenue up 7% year-on-year as of May 31, WH Smith is poised to benefit from focused growth initiatives amidst high debt levels and evolving market dynamics.
Unlock comprehensive insights into our analysis of WH Smith stock in this valuation report.
Assess WH Smith's past performance with our detailed historical performance reports.
Simply Wall St Value Rating: ★★★☆☆☆
Overview: NOTE is a technology company specializing in manufacturing and supplying electronics to various industries, with a market capitalization of SEK 6.88 billion.
Operations: The company generates revenue primarily from Western Europe (SEK 2.99 billion) and the Rest of World (SEK 905 million). Its cost structure is dominated by the cost of goods sold, which has consistently been a significant portion of revenue. Notably, the gross profit margin has shown variability, reaching as high as 13.54% in recent periods.
PE: 18.2x
NOTE AB's recent performance highlights its potential as an undervalued opportunity among European small companies. Despite a slight dip in Q1 sales to SEK 1,003 million from SEK 1,055 million last year, net income rose to SEK 65 million. Insider confidence is evident with Director Johan Hagberg purchasing shares worth approximately SEK 600,416 in April. Although reliant on external borrowing for funding, NOTE forecasts a promising earnings growth of 13% annually. The company anticipates Q2 sales between SEK 950-1,050 million.
Get an in-depth perspective on NOTE's performance by reading our valuation report here.
Gain insights into NOTE's historical performance by reviewing our past performance report.
Get an in-depth perspective on all 78 Undervalued European Small Caps With Insider Buying by using our screener here.
Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include LSE:GLE LSE:SMWH and OM:NOTE.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Morgan Stanley Reduces PT on Jazz Pharmaceuticals plc (JAZZ) from $166 to $165; Maintains ‘Buy' Rating
Morgan Stanley Reduces PT on Jazz Pharmaceuticals plc (JAZZ) from $166 to $165; Maintains ‘Buy' Rating

Yahoo

time26 minutes ago

  • Yahoo

Morgan Stanley Reduces PT on Jazz Pharmaceuticals plc (JAZZ) from $166 to $165; Maintains ‘Buy' Rating

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is included in our list of the 10 Most Undervalued Foreign Stocks to Buy According to Analysts. A closeup of pills in a pharmacy, representing the high quality medications of the company. Despite early-year challenges, Jazz Pharmaceuticals plc (NASDAQ:JAZZ) remains a 'Buy'. On July 22, 2025, Morgan Stanley maintained its 'Buy' rating on JAZZ. However, the analyst lowered its price target slightly from $166 to $165. The analyst attributes its bullish stance to its expectation that the company will bounce back in the second half of the year, following a 10% miss in its Q1 net product sales. This expectation is driven by an extra shipping week in the Oncology segment, stronger demand for Rylaze due to pediatric protocol shifts, and seasonal strength in sleep disorder medication. Meanwhile, Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is expected to experience major clinical developments with HERIZON-GEA-01 data and the anticipated dordaviprone FDA decision. Furthermore, the upcoming leadership change boosts optimism. Looking ahead, the analyst's oncology revenue estimate exceeds the street's estimates. On the other hand, Wells Fargo reinforced this outlook, maintaining a 'Buy' rating on July 18 with a price target of $170. Operating in the United States, Europe, and other global markets, Jazz Pharmaceuticals plc (NASDAQ:JAZZ) develops and commercializes pharmaceutical products. It remains on our list of the most undervalued stocks. While we acknowledge the potential of JAZZ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 14 Cheap Transportation Stocks to Buy According to Analysts and 10 Cheap Lithium Stocks to Buy According to Hedge Funds. Disclosure: None.

Scotiabank Upgrades Globant S.A. (GLOB) to ‘Outperform'; Maintains $115 PT
Scotiabank Upgrades Globant S.A. (GLOB) to ‘Outperform'; Maintains $115 PT

Yahoo

time26 minutes ago

  • Yahoo

Scotiabank Upgrades Globant S.A. (GLOB) to ‘Outperform'; Maintains $115 PT

Globant S.A. (NYSE:GLOB) is included in our list of the . On July 21, 2025, Scotiabank upgraded its rating on Globant S.A. (NYSE:GLOB) to 'Outperform'. Maintaining a $115 price target, the analyst cited the company's industry-leading capabilities and increased capacity to meet the growing demand for AI-driven enterprise solutions. Scotiabank also considers the company's Service-as-a-Software (SaaS) model that integrates AI-led workflows across business operations. This upgrade from the analyst follows a challenging 2025 so far. A 54% YoY decline in Globant S.A. (NYSE:GLOB)'s shares was noted in Alger Mid Cap Focus Fund's Q2 2025 investor letter, following weaker-than-expected Q1 results. The company attributed its weak Q1 performance to project delays, especially in North America, amid ongoing macroeconomic uncertainty. Globant S.A. (NYSE:GLOB), a Luxembourg-based technology services firm, leverages AI, cloud, software development, and enterprise solutions to help businesses transform digitally. It remains on our list of the most undervalued stocks. While we acknowledge the potential of GLOB as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 14 Cheap Transportation Stocks to Buy According to Analysts and 10 Cheap Lithium Stocks to Buy According to Hedge Funds. Disclosure: None. Sign in to access your portfolio

Airbus Agrees To Additional $94 Million Support For Spirit AeroSystems Holdings, Inc. (SPR)
Airbus Agrees To Additional $94 Million Support For Spirit AeroSystems Holdings, Inc. (SPR)

Yahoo

time26 minutes ago

  • Yahoo

Airbus Agrees To Additional $94 Million Support For Spirit AeroSystems Holdings, Inc. (SPR)

Spirit AeroSystems Holdings, Inc. (NYSE:SPR) is among the 10 Best Aerospace Stocks to Buy Now. According to recent press reports, Airbus has agreed to provide additional support worth $94 million to the aerostructures supplier, bringing the total financial support to $152 million. The financial assistance comes in the form of advance payments for aircraft parts. However, the money is to be used exclusively for Airbus programs. Earlier this year, Airbus announced the signing of a definitive agreement to acquire several industrial assets of Spirit AeroSystems Holdings, Inc. (NYSE: SPR) dedicated to commercial aircraft programs, including the production of A220 wings in Belfast, Northern Ireland. Latest accounts for Spirit AeroSystems Holdings, Inc. (NYSE:SPR)'s Belfast factory, which is split between Airbus and Boeing, reveal the facility's losses have ballooned from $338 million to $506 million for the year ended December 2024. Auditors have warned that without further external support, the factory may not stay afloat by the end of September next year. While we acknowledge the potential of SPR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Best Global Stocks to Buy Right Now and 10 Best Small Cap Defense Stocks to Buy According to Hedge Funds. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store